[go: up one dir, main page]

GB202002072D0 - immunoglobulin detection and associated therapies - Google Patents

immunoglobulin detection and associated therapies

Info

Publication number
GB202002072D0
GB202002072D0 GBGB2002072.3A GB202002072A GB202002072D0 GB 202002072 D0 GB202002072 D0 GB 202002072D0 GB 202002072 A GB202002072 A GB 202002072A GB 202002072 D0 GB202002072 D0 GB 202002072D0
Authority
GB
United Kingdom
Prior art keywords
associated therapies
immunoglobulin detection
immunoglobulin
detection
therapies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2002072.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hansa Biopharma AB
Original Assignee
Hansa Biopharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hansa Biopharma AB filed Critical Hansa Biopharma AB
Priority to GBGB2002072.3A priority Critical patent/GB202002072D0/en
Publication of GB202002072D0 publication Critical patent/GB202002072D0/en
Priority to CA3167601A priority patent/CA3167601A1/en
Priority to CN202180028468.XA priority patent/CN115398241A/en
Priority to US17/799,309 priority patent/US20230110085A1/en
Priority to EP21705919.5A priority patent/EP4103947A1/en
Priority to JP2022549095A priority patent/JP2023514270A/en
Priority to AU2021220629A priority patent/AU2021220629A1/en
Priority to PCT/EP2021/053462 priority patent/WO2021160805A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96466—Cysteine endopeptidases (3.4.22)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB2002072.3A 2020-02-14 2020-02-14 immunoglobulin detection and associated therapies Ceased GB202002072D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB2002072.3A GB202002072D0 (en) 2020-02-14 2020-02-14 immunoglobulin detection and associated therapies
CA3167601A CA3167601A1 (en) 2020-02-14 2021-02-12 Immunoglobulin detection and associated therapies
CN202180028468.XA CN115398241A (en) 2020-02-14 2021-02-12 Immunoglobulin detection and related treatments
US17/799,309 US20230110085A1 (en) 2020-02-14 2021-02-12 Immunoglobulin detection and associated therapies
EP21705919.5A EP4103947A1 (en) 2020-02-14 2021-02-12 Immunoglobulin detection and associated therapies
JP2022549095A JP2023514270A (en) 2020-02-14 2021-02-12 Immunoglobulin detection and associated therapy
AU2021220629A AU2021220629A1 (en) 2020-02-14 2021-02-12 Immunoglobulin detection and associated therapies
PCT/EP2021/053462 WO2021160805A1 (en) 2020-02-14 2021-02-12 Immunoglobulin detection and associated therapies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2002072.3A GB202002072D0 (en) 2020-02-14 2020-02-14 immunoglobulin detection and associated therapies

Publications (1)

Publication Number Publication Date
GB202002072D0 true GB202002072D0 (en) 2020-04-01

Family

ID=69956564

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2002072.3A Ceased GB202002072D0 (en) 2020-02-14 2020-02-14 immunoglobulin detection and associated therapies

Country Status (8)

Country Link
US (1) US20230110085A1 (en)
EP (1) EP4103947A1 (en)
JP (1) JP2023514270A (en)
CN (1) CN115398241A (en)
AU (1) AU2021220629A1 (en)
CA (1) CA3167601A1 (en)
GB (1) GB202002072D0 (en)
WO (1) WO2021160805A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023086003A1 (en) * 2021-11-10 2023-05-19 Fellstroem Bengt TREATMENT OF ADVANCED IgA NEPHROPATHY
KR20240155358A (en) * 2022-03-17 2024-10-28 아스트라제네카 아일랜드 리미티드 Improved IgG-degrading enzyme and method of using the same
CN116297120B (en) * 2023-03-30 2023-12-01 深圳市血液中心(深圳市输血医学研究所) Method for detecting drug antibody in sample
WO2025047641A1 (en) * 2023-08-25 2025-03-06 積水メディカル株式会社 Immunological measurement method, reagent for immunological measurement, specimen pretreatment liquid for immunological measurement, reagent kit for immunological measurement, and non-specific reaction inhibitor
CN117467015B (en) * 2023-12-27 2024-03-12 北京索莱宝科技有限公司 Antibodies, antibody combinations and uses of human IgA

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
JP5722627B2 (en) * 2007-09-14 2015-05-27 ジェノビス エービー Methods and kits for dissociation of FC gamma receptor-IgG complex and purification and detection of IgG
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
WO2014025895A1 (en) * 2012-08-08 2014-02-13 Arryx, Inc. Methods and devices for immunodiagnostic applications
GB201413240D0 (en) * 2014-07-25 2014-09-10 Hansa Medical Ab Method
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502305D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
PL3411389T3 (en) * 2016-02-04 2021-10-25 Genovis Ab New streptococcal proteases

Also Published As

Publication number Publication date
US20230110085A1 (en) 2023-04-13
WO2021160805A1 (en) 2021-08-19
EP4103947A1 (en) 2022-12-21
JP2023514270A (en) 2023-04-05
CA3167601A1 (en) 2021-08-19
CN115398241A (en) 2022-11-25
AU2021220629A1 (en) 2022-09-01

Similar Documents

Publication Publication Date Title
GB202002072D0 (en) immunoglobulin detection and associated therapies
IL283695A (en) Systems and methods for behavioral threat detection
IL275737A (en) Antibodies and variants thereof against tigit
GB202108893D0 (en) Cryptocurrency based malware and ransomware detection systems and methods
IL283698A (en) Systems and methods for behavioral threat detection
GB202108277D0 (en) Methods and systems for speech detection
IL275734B (en) Anti-pd-l1 antibodies and uses thereof
SG11202110410UA (en) Detection method and detection system
EP4082451A4 (en) CLOSURE AND SYSTEM
SG11202009990UA (en) Modified antibody and radioactive metal-labelled antibody
SG11202011154RA (en) Detection device and detection system
ZA202006255B (en) Anti-pd-l1 antibody and use thereof
GB2578339B (en) Open PEN detection and shut down system
SG11202011193PA (en) Detection device and detection system
GB201910654D0 (en) System event detection system and method
SG11202110011WA (en) Analysis systems and methods
PL3508680T3 (en) Sealing device and sectional door with same
IL283697A (en) Systems and methods for behavioral threat detection
IL285569A (en) Anti-pd-l1 antibody and use thereof
EP3827374A4 (en) Methods and apparatuses for corner detection
SG11202102659RA (en) Anti-human cd45rc antibodies and uses thereof
IL292149A (en) Systems and methods for infrared sensing
ZA202210284B (en) Anti-trem1 antibodies and related methods
EP3864411A4 (en) Antibody or aptamer conjugated-lipid vesicles and detection methods and microfluidics devices using same
PL3591402T3 (en) Device and method for antibody detection

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)